Prof. Thomas Hedner
Thomas Hedner, born 1949, professor and chairman of Clinical Pharmacology at Sahlgrenska Academy at University of Göteborg, Sweden. Physician and Economist (MBA). Educated and trained at Sahlgrenska Academy (Sahlgrenska University Hospital) and School of Economics, University of Göteborg and Innovation and Entrepreneurship, Faculty of Economics, Linköping University, Sweden. Present position as professor and acting chairman in Clinical Pharmacology, Sahlgrenska University Hospital in Göteborg since 1993. Member of national as well as international general medical associations, member of ESH, ISH and ASH as well as IASP. Board member of the Swedish Hypertension Society 1993-2003. Received the International Society of Hypertension/Schering Corporation Research Fellowship 1986 and the Sten Gustafsson Prize in Innovation and Entrepreneurship from the Swedish Royal Society of Engineering Sciences (IVA) in 2008. Elected member of RIFO (Riksdagsmän och Forskare) in 2012. Present medical research interests are primarily related to cardiovascular clinical pharmacology. Author or co-author of more than 500 scientific papers in international peer-reviewed medical journals, of which approximately 100 are published during the last 10 years. Some extensively cited, altogether more than 10.000 SCOPUS points. Master of Business Administration (MBA) at the School of Economics and Commercial Law at Göteborg 2005. Presented an additional PhD in Economics (Innovation and Entrepreneurship) February 2012, on the thesis “Change in the Pharmaceutical Industry”. Economics research includes change processes in the pharmaceutical industry, open innovation, entrepreneurial decision making, venture creation and SME growth at the School of Economics, Linköping University, Sweden. Innovator and entrepreneur and founder of several biomedical start-ups (Blood Pressure AB, DuoCort AB, Laccure AB) and active as a board member (AnaMar AB, Smartsun AB).